Intuitive Surgical disclosed a phishing-linked cyber breach Friday as medtech peer Stryker also faced a major attack, heightening investor focus on cybersecurity risks across the sector.
A medical technology company based in the United States, Stryker ( NYSE:SYK ) entered 2026 on the back of record Mako robotic installations and its first-ever $25 billion revenue year, only to have that momentum completely interrupted by a destructive cyberattack that paralyzed order processing, manufacturing, and shipping.
Despite the unusual and surprising news, the stock still followed a predictable pattern. This is why Stryker is the Stock of the Day.
Stryker (SYK) shares came under pressure after a cyberattack forced the medical technology company to keep its ordering and shipping systems offline, raising co
Medical device maker Stryker said on Thursday a cyberattack that hit its computer systems a day earlier is causing widespread disruption to its business, including its ability to process orders, make products and ship them to customers.
Citi is making a clear statement about the health of U.S. medical technology heading into the spring: the sector's fundamentals remain intact, even as broader market volatility has dragged down some of the industry's strongest names.
SYK unveils SmartHospital Platform to link devices, data and care teams, aiming to boost hospital efficiency, clinical decisions and digital transformation.
SYK unveils new Triathlon knee implants, and expands Mako robotics and power tools, deepening its tech-driven orthopedics moat despite recent stock dip.
SYK launches Synchfix EVT, a next-gen ankle fixation system designed to streamline surgery and expand reach into adolescent trauma care.
SYK launches the T2 Alpha Humerus Nailing System to enhance complex fracture care, boosting procedural efficiency and strengthening its trauma portfolio.
SYK shares rise after fourth-quarter EPS and sales top estimates, fueled by double-digit organic growth and strong adoption of its Mako platform.
Stryker Corporation (SYK) Q4 2025 Earnings Call Transcript